Biotech Consulting & Cross-Border Pharma Advisory
Life science consulting for licensing, M&A, partnerships, and deal-making across global pharma and biotech.
In-Licensing
Acquire rights to innovative therapeutics and technologies.
Out-Licensing
Monetize your IP and product portfolios globally.
Strategic Partnerships
Build cross-border alliances in pharma and biotech.
Global Network
Deep connections across Asia, Europe, and USA.
Your Partner in Cross-Border Life Sciences Deals
We facilitate global partnerships and financing in life sciences, connecting Asia, Europe, and USA to accelerate innovation to market.
Global
Tri-Continental Network
Proven
Cross-Border Deal Expertise
Billions
In Transaction Opportunity
Solutions for Life Sciences Cross-Border Collaborations
In-Licensing. Acquire rights to innovative therapeutics and technologies from global partners.
Out-Licensing. Monetize your IP and product portfolios through strategic licensing agreements.
Strategic Partnerships. Build cross-border alliances for drug development, manufacturing, and commercialization.
Connected
Global Partner Ecosystem
NewCo Formation. Spin off assets into new independent entities to access global capital and expertise.
Launched
Multiple NewCos to Market
Capital Access. Connect clients with investors and structure financial deals from seed to late-stage.
Funded
Capital Raised
Core Capabilities for Pharmaceutical and Biotech Success
Our specialized knowledge and vast connections make us the ideal catalyst for cross-border collaborations in the life sciences industry.
Maximize value in licensing transactions.
We facilitate in-licensing agreements, balancing upfront payments, milestones, and royalties for optimal outcomes. Our expertise ensures you secure the right assets at the right terms.
